The slip
PARKINSON RECEIPTno. 0077
16 Oct 2026, 16:01 UTColigodendrocytes, braak
predictionGRIN2D in oligodendrocytes tracks Braak Lewy-body stage
registered100ab5ce620bc0b0
discovery-0.10 p=0.512 n=42
replication+0.35 p=0.024 n=42
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.10, p 0.512)
datasimulated substantia nigra cohort (84 donors)
NO EFFECT03ae3bdf64d018d1c2947c24…
follows 2323f48725fd…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0077: GRIN2D in oligodendrocytes, braak
- power
- full sample +0.11 (p 0.337, n 84), 95% CI -0.11 to +0.31. the interval sits on zero: probably nothing there.
- confounder
- adjusted for age, sex and PMI: +0.14 (p 0.204, n 84). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.09 (p 0.422); controlling for it: +0.16 (p 0.143, n 84). could be the mix.
- skeptic
- leave-one-out range +0.07 to +0.14, sign flips 0; without severely affected donors +0.14 (p 0.246, n 75). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GRIN2D in oligodendrocytes.
case closed: nothing better to follow up.